Literature DB >> 8814687

Prognostic value of resection-line involvement in patients undergoing curative resections for gastric cancer.

I Songun1, J J Bonenkamp, J Hermans, J H van Krieken, C J van de Velde.   

Abstract

Prognostic value of microscopical resection-line involvement of the proximal and distal resection lines was examined in patients undergoing potentially curative resection in a multicentre trial with strict quality control. Tumour-positive resection lines were seen in 41 of the 699 evaluable patients (5.9%). Resection-line involvement was associated with T stage (P < 0.001), N stage (P = 0.003), tumour location (P < 0.001) and tumour differentiation (P < 0.001). Presence of resection-line involvement was also associated with significantly worse survival. Together with T3 and T4 stage (relative risk (RR) 2.04), N(+) stage (RR 4.02) and tumour differentiation (RR 1.33), resection-line involvement (RR 2.28) was also an independent prognostic factor for survival. Survival in patients with resection-line involvement was comparable with patients with positive cytology. In patients undergoing potentially curative resection for gastric cancer, peri-operative frozen-section examination should be mandatory, especially in those with poorly differentiated, signet ring cell or anaplastic tumours, with tumours covering the entire stomach and T3 or T4 tumours. In case of tumour-positive margin(s) at final histology, re-laparotomy could be considered if achieving tumour-free resection lines seems realistic.

Entities:  

Mesh:

Year:  1996        PMID: 8814687     DOI: 10.1016/0959-8049(95)00591-9

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  27 in total

1.  Treatment of resectable gastric cancer.

Authors:  Johan L Dikken; Cornelis J H van de Velde; Daniel G Coit; Manish A Shah; Marcel Verheij; Annemieke Cats
Journal:  Therap Adv Gastroenterol       Date:  2012-01       Impact factor: 4.409

2.  Prognostic impact of microscopic tumor involved resection margin in advanced gastric cancer patients after gastric resection.

Authors:  Jung-Woo Woo; Keun Won Ryu; Ji Yeon Park; Bang Wool Eom; Mi Jung Kim; Hong Man Yoon; Sook Ryun Park; Myeong-Cherl Kook; Il Ju Choi; Young-Woo Kim; Young-Iee Park
Journal:  World J Surg       Date:  2014-02       Impact factor: 3.352

Review 3.  [R1 resection for gastric carcinoma].

Authors:  K Ridwelski; J Fahlke; M Huß; R Otto; S Wolff
Journal:  Chirurg       Date:  2017-09       Impact factor: 0.955

4.  Should we remove splenic hilus lymph nodes for esophagogastric junction adenocarcinoma?

Authors:  H H Hartgrink
Journal:  Gastric Cancer       Date:  2013-10       Impact factor: 7.370

5.  Influence of a microscopic positive proximal margin in the treatment of gastric adenocarcinoma of the cardia.

Authors:  Jian-Guo Shen; Jae-Ho Cheong; Woo-Jin Hyung; Junuk Kim; Seung-Ho Choi; Sung-Hoon Noh
Journal:  World J Gastroenterol       Date:  2006-06-28       Impact factor: 5.742

6.  Duodenal fistula after elective gastrectomy for malignant disease : an italian retrospective multicenter study.

Authors:  Luca Cozzaglio; Massimiliano Coladonato; Roberto Biffi; Arianna Coniglio; Vittorio Corso; Paolo Dionigi; Luca Gianotti; Vincenzo Mazzaferro; Paolo Morgagni; Fausto Rosa; Riccardo Rosati; Francesco Roviello; Roberto Doci
Journal:  J Gastrointest Surg       Date:  2010-02-09       Impact factor: 3.452

7.  Accuracy of diagnostic demarcation of undifferentiated-type early gastric cancer for magnifying endoscopy with narrow-band imaging: surgical cases.

Authors:  Yusuke Horiuchi; Junko Fujisaki; Noriko Yamamoto; Tomoki Shimizu; Masami Omae; Akiyoshi Ishiyama; Toshiyuki Yoshio; Toshiaki Hirasawa; Yorimasa Yamamoto; Tomohiro Tsuchida; Masahiro Igarashi; Hiroshi Takahashi
Journal:  Surg Endosc       Date:  2016-08-29       Impact factor: 4.584

8.  Resection line involvement after gastric cancer surgery: clinical outcome in nonsurgically retreated patients.

Authors:  P Morgagni; D Garcea; D Marrelli; G De Manzoni; G Natalini; H Kurihara; A Marchet; L Saragoni; E Scarpi; C Pedrazzani; A Di Leo; F De Santis; V Panizzo; D Nitti; F Roviello
Journal:  World J Surg       Date:  2008-12       Impact factor: 3.352

9.  Gastric cancer.

Authors:  Henk H Hartgrink; Edwin P M Jansen; Nicole C T van Grieken; Cornelis J H van de Velde
Journal:  Lancet       Date:  2009-07-20       Impact factor: 79.321

10.  Risk factor analysis for involvement of resection margins in gastric and esophagogastric junction cancer: an Italian multicenter study.

Authors:  Massimiliano Bissolati; Matteo Desio; Fausto Rosa; Stefano Rausei; Daniele Marrelli; Gian Luca Baiocchi; Giovanni De Manzoni; Damiano Chiari; Giovanni Guarneri; Fabio Pacelli; Lorenzo De Franco; Sarah Molfino; Chiara Cipollari; Elena Orsenigo
Journal:  Gastric Cancer       Date:  2016-01-05       Impact factor: 7.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.